BioTouch is investing $12.5 million in Columbus, Georgia to expand its facility operations and add 480 jobs. The investment supports production capacity growth and workforce expansion in the local manufacturing sector.
BioTouch has announced a $12.5 million capital investment in facility expansions at its operations in Columbus, Georgia, intended to support increased production capacity and the creation of approximately 480 jobs in the region. The announced expansion encompasses upgrades and enlargement of existing manufacturing and operational space, positioning the company to meet growing demand for its products.
The Columbus facility serves as a key production and distribution site for BioTouch’s portfolio of offerings. The planned enhancements will include expansion of manufacturing lines, improvements to on-site infrastructure, and potential reconfiguration of existing space to support new equipment and workforce needs. The investment is part of a broader strategic initiative to scale operations while reinforcing the company’s presence in the Southeast manufacturing market.
Local and state economic development entities have supported the project through coordination with BioTouch leadership to facilitate permitting, workforce planning and infrastructure alignment. The jobs anticipated through the expansion are expected to span production, technical support, supervisory roles and administrative functions. BioTouch has initiated recruitment efforts in collaboration with community workforce development partners to fill the new positions as the expanded facility comes online.
The Columbus, Georgia expansion reflects ongoing corporate investment in domestic manufacturing capacity and local employment growth. BioTouch’s capital deployment is consistent with broader regional trends in advanced manufacturing investment that leverage transportation access, workforce availability and utility infrastructure.